v3.25.2

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 5,097,670	$ 7,819,514
Deferred issuance cost	31,682	103,847
Prepaid expenses and other current assets	191,100	905,269
Total current assets	5,320,452	8,828,630
Security deposit	22,777	22,777
Office furniture and equipment, net	8,114	6,113
Right-of-use lease assets	409,304	108,963
Total assets	5,760,647	8,966,483
Current liabilities:
Accounts payable	649,955	667,896
Accrued expenses	2,783,149	2,359,339
Accrued compensation	87,189	336,442
Lease liabilities, current	108,814	111,862
Convertible debt		1,372,873
Total current liabilities	3,629,107	4,848,412
Non-current liabilities:
Lease liabilities, net of current portion	302,589
Total liabilities	3,931,696	4,848,412
Commitments and contingencies (Note 6)
Shareholders' equity:
Preferred stock, 350,000 shares authorized; none issued or outstanding at June 30, 2025 and December 31, 2024, respectively
Common stock, $.001 par value; 75,000,000 shares authorized; 3,504,950 and 2,514,499 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	3,505	2,514
Additional paid-in capital	241,403,653	238,040,520
Accumulated other comprehensive income	45,789	45,789
Accumulated deficit	(239,623,996)	(233,970,752)
Total shareholders' equity	1,828,951	4,118,071
Total liabilities and shareholders' equity	$ 5,760,647	$ 8,966,483

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

SOLIGENIX, INC. 10-Q